These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1659424)

  • 41. Flow cytofluorometry in tumour cell receptor analysis. Survey of the literature and recent developments concerning the urokinase-type plasminogen activator (uPA).
    Chucholowski N; Schmitt M; Goretzki L; Schüren E; Moniwa N; Weidle U; Kramer M; Wagner B; Jänicke F; Graeff H
    Biochem Soc Trans; 1992 Feb; 20(1):208-16. PubMed ID: 1321752
    [No Abstract]   [Full Text] [Related]  

  • 42. Antisense oligonucleotides against the urokinase receptor: a therapeutic strategy for the control of cell invasion in rheumatoid arthritis and cancer.
    Del Rosso M; Fibbi G; Pucci M; Cerinic MM
    Clin Exp Rheumatol; 1998; 16(4):389-93. PubMed ID: 9706415
    [No Abstract]   [Full Text] [Related]  

  • 43. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
    Lundgren CH; Sawa H; Sobel BE; Fujii S
    Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells.
    Hjertner O; Qvigstad G; Hjorth-Hansen H; Seidel C; Woodliff J; Epstein J; Waage A; Sundan A; Börset M
    Br J Haematol; 2000 Jun; 109(4):815-22. PubMed ID: 10929035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells. Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface.
    Ragno P; Montuori N; Rossi G
    Eur J Biochem; 1995 Oct; 233(2):514-9. PubMed ID: 7588796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.
    Yang JL; Seetoo Dq; Wang Y; Ranson M; Berney CR; Ham JM; Russell PJ; Crowe PJ
    Int J Cancer; 2000 Sep; 89(5):431-9. PubMed ID: 11008205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in synovial fluid of patients with temporomandibular disorders].
    Hu L; Liang XH; Zhu GQ; Hu J; Shi ZD
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Mar; 43(3):160-3. PubMed ID: 18788551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA; Medcalf RL; Kruithof EK
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation.
    Schlechte W; Murano G; Boyd D
    Cancer Res; 1989 Nov; 49(21):6064-9. PubMed ID: 2551498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes.
    Seishima M; Satoh S; Nojiri M; Osada K; Kitajima Y
    J Invest Dermatol; 1997 Nov; 109(5):650-5. PubMed ID: 9347794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.
    Tecimer C; Doering DL; Goldsmith LJ; Meyer JS; Abdulhay G; Wittliff JL
    Gynecol Oncol; 2001 Jan; 80(1):48-55. PubMed ID: 11136569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urokinase and its receptor: marker of malignancy?
    Gaffney PJ; Cooke DA; Burnand KG
    Adv Exp Med Biol; 1994; 360():187-91. PubMed ID: 7872083
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells.
    Nykjaer A; Petersen CM; Møller B; Andreasen PA; Gliemann J
    FEBS Lett; 1992 Mar; 300(1):13-7. PubMed ID: 1312484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical staining of urokinase plasminogen activator-like and urokinase plasminogen activator receptor-like proteins in the urinary tract of healthy dogs.
    Bailey TR; Paulsen DB; Sehgal I; Hosgood G
    Am J Vet Res; 2006 Sep; 67(9):1628-34. PubMed ID: 16948613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasminogen activator and receptor in osteoarthritis.
    Serni U; Fibbi G; Anichini E; Zamperini A; Pucci M; Mannoni A; Matucci A; Benucci M; Del Rosso A; Del Rosso M
    J Rheumatol Suppl; 1995 Feb; 43():120-2. PubMed ID: 7752114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
    Braungart E; Magdolen V; Degitz K
    J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.